Apellis’ Syfovre Sales Overshadowed By Safety Concerns

 
• By Jessica Merrill
  
bumpy road
Apellis forecasts bumpy sales of Syfovre ahead. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Sensory

More from Therapeutic Category